[{"Assets_0_Q3_USD":87215000.0,"CommonStockSharesOutstanding_0_Q3_shares":15126000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":1093000.0,"NetIncomeLoss_1_Q3_USD":-7433000.0,"NetIncomeLoss_3_Q3_USD":-15002000.0,"StockholdersEquity_0_Q3_USD":35895000.0,"Ticker":"ARCT","CIK":"1768224","name":"ARCTURUS THERAPEUTICS HOLDINGS INC.","OfficialName":"Arcturus Therapeutics Holdings Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"666232551.0","Country":"Israel","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191108"}]